We are thrilled to celebrate our 10th anniversary, marking a decade of achievements that reflect our unwavering commitment to ion channel research, cardiac safety screening and neuroscience services. Since our founding in 2015 we have worked tirelessly to fulfil our mission: to deliver specialist advice and expertise, high-quality data, and exceptional customer service, empowering the success of our customers’ preclinical pharmaceutical research and development.
From the outset, we’ve stayed true to our vision of becoming the global biopharmaceutical industry’s first-choice CRO for ion channel drug discovery, cardiac safety, and neuroscience services. Our commitment to delivering innovative, reliable, and customer-focused solutions has made us a trusted partner to pharmaceutical and biotechnology companies worldwide.
Our core values of scientific excellence, integrity, collaboration, and a passion for innovation have guided us throughout this journey. We’ve built a reputation as a leading centre of expertise in drug discovery research, thanks to our exceptional team of highly experienced scientists. By fostering a culture of collaboration and innovation, we’ve been able to deliver high-quality, reproducible data that meets the rigorous standards of our industry, consistently exceeding customer expectations.
As a company, we’ve embraced the principle that our customers’ success is our success. This belief drives our customer-focused approach, enabling us to build strong, collaborative relationships. By listening to, and understanding, their unique challenges and objectives, we’ve delivered tailored solutions that accelerate their drug discovery programmes and help them achieve their goals.
Innovation is at the heart of everything we do. Over the past decade, we’ve made significant advancements in our technologies and methodologies. Our ability to maintaining the highest standards of scientific integrity reflects our dedication to our mission and values.
As we celebrate this significant milestone, we take pride in the contributions of our entire team, whose expertise and dedication have been instrumental in shaping who we are today. We’re equally grateful to our customers and collaborators, whose trust and partnership have been pivotal to our success.
Looking ahead, we remain steadfast in our commitment to our mission, vision, and values as we continue to grow and evolve. We are excited about the opportunities the future holds and remain dedicated to driving progress in preclinical drug discovery research, making lasting contributions to human health.
Here’s to many more years of success as we continue our journey together.
We are thrilled to celebrate our 10th anniversary, marking a decade of achievements that reflect our unwavering commitment to ion channel research, cardiac safety screening and neuroscience services. Since our founding in 2015 we have worked tirelessly to fulfil our mission: to deliver specialist advice and expertise, high-quality data, and exceptional customer service, empowering the success of our customers’ preclinical pharmaceutical research and development.
From the outset, we’ve stayed true to our vision of becoming the global biopharmaceutical industry’s first-choice CRO for ion channel drug discovery, cardiac safety, and neuroscience services. Our commitment to delivering innovative, reliable, and customer-focused solutions has made us a trusted partner to pharmaceutical and biotechnology companies worldwide.
Our core values of scientific excellence, integrity, collaboration, and a passion for innovation have guided us throughout this journey. We’ve built a reputation as a leading centre of expertise in drug discovery research, thanks to our exceptional team of highly experienced scientists. By fostering a culture of collaboration and innovation, we’ve been able to deliver high-quality, reproducible data that meets the rigorous standards of our industry, consistently exceeding customer expectations.
As a company, we’ve embraced the principle that our customers’ success is our success. This belief drives our customer-focused approach, enabling us to build strong, collaborative relationships. By listening to, and understanding, their unique challenges and objectives, we’ve delivered tailored solutions that accelerate their drug discovery programmes and help them achieve their goals.
Innovation is at the heart of everything we do. Over the past decade, we’ve made significant advancements in our technologies and methodologies. Our ability to maintaining the highest standards of scientific integrity reflects our dedication to our mission and values.
As we celebrate this significant milestone, we take pride in the contributions of our entire team, whose expertise and dedication have been instrumental in shaping who we are today. We’re equally grateful to our customers and collaborators, whose trust and partnership have been pivotal to our success.
Looking ahead, we remain steadfast in our commitment to our mission, vision, and values as we continue to grow and evolve. We are excited about the opportunities the future holds and remain dedicated to driving progress in preclinical drug discovery research, making lasting contributions to human health.
Here’s to many more years of success as we continue our journey together.
We are thrilled to celebrate our 10th anniversary, marking a decade of achievements that reflect our unwavering commitment to ion channel research, cardiac safety screening and neuroscience services. Since our founding in 2015 we have worked tirelessly to fulfil our mission: to deliver specialist advice and expertise, high-quality data, and exceptional customer service, empowering the success of our customers’ preclinical pharmaceutical research and development.
From the outset, we’ve stayed true to our vision of becoming the global biopharmaceutical industry’s first-choice CRO for ion channel drug discovery, cardiac safety, and neuroscience services. Our commitment to delivering innovative, reliable, and customer-focused solutions has made us a trusted partner to pharmaceutical and biotechnology companies worldwide.
Our core values of scientific excellence, integrity, collaboration, and a passion for innovation have guided us throughout this journey. We’ve built a reputation as a leading centre of expertise in drug discovery research, thanks to our exceptional team of highly experienced scientists. By fostering a culture of collaboration and innovation, we’ve been able to deliver high-quality, reproducible data that meets the rigorous standards of our industry, consistently exceeding customer expectations.
As a company, we’ve embraced the principle that our customers’ success is our success. This belief drives our customer-focused approach, enabling us to build strong, collaborative relationships. By listening to, and understanding, their unique challenges and objectives, we’ve delivered tailored solutions that accelerate their drug discovery programmes and help them achieve their goals.
Innovation is at the heart of everything we do. Over the past decade, we’ve made significant advancements in our technologies and methodologies. Our ability to maintaining the highest standards of scientific integrity reflects our dedication to our mission and values.
As we celebrate this significant milestone, we take pride in the contributions of our entire team, whose expertise and dedication have been instrumental in shaping who we are today. We’re equally grateful to our customers and collaborators, whose trust and partnership have been pivotal to our success.
Looking ahead, we remain steadfast in our commitment to our mission, vision, and values as we continue to grow and evolve. We are excited about the opportunities the future holds and remain dedicated to driving progress in preclinical drug discovery research, making lasting contributions to human health.
Here’s to many more years of success as we continue our journey together.